Eileen Holovac

1.2k total citations
10 papers, 872 citations indexed

About

Eileen Holovac is a scholar working on Pharmacology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eileen Holovac has authored 10 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Pathology and Forensic Medicine and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eileen Holovac's work include Cannabis and Cannabinoid Research (4 papers), Diet, Metabolism, and Disease (3 papers) and Liver Disease and Transplantation (2 papers). Eileen Holovac is often cited by papers focused on Cannabis and Cannabinoid Research (4 papers), Diet, Metabolism, and Disease (3 papers) and Liver Disease and Transplantation (2 papers). Eileen Holovac collaborates with scholars based in United States, Hungary and China. Eileen Holovac's co-authors include Partha Mukhopadhyay, Pál Pacher, György Haskó, Lucas Liaudet, Béla Horváth, Malek Kechrid, Katalin Erdélyi, Zongxian Cao, Wen-Shin Lee and Sándor Bátkai and has published in prestigious journals such as Gastroenterology, Hepatology and Diabetes.

In The Last Decade

Eileen Holovac

10 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eileen Holovac United States 6 274 268 189 141 128 10 872
Malek Kechrid United States 5 167 0.6× 232 0.9× 208 1.1× 82 0.6× 97 0.8× 9 712
Galin Tanchian United States 7 310 1.1× 251 0.9× 224 1.2× 89 0.6× 108 0.8× 10 820
Koh-ichi Yuhki Japan 14 360 1.3× 303 1.1× 101 0.5× 130 0.9× 92 0.7× 17 1.0k
Xiaofang Fan China 21 253 0.9× 536 2.0× 55 0.3× 100 0.7× 247 1.9× 91 1.4k
Hongyin Du China 19 128 0.5× 265 1.0× 94 0.5× 65 0.5× 134 1.0× 46 947
Italia Papparella Italy 16 175 0.6× 562 2.1× 76 0.4× 255 1.8× 129 1.0× 25 1.4k
Elisa Benetti Italy 19 66 0.2× 569 2.1× 173 0.9× 103 0.7× 163 1.3× 41 1.4k
Entesar F. Amin Egypt 13 60 0.2× 155 0.6× 111 0.6× 120 0.9× 73 0.6× 15 583
Akiyoshi Hara Japan 16 371 1.4× 405 1.5× 359 1.9× 80 0.6× 115 0.9× 50 1.4k
Saadet Türkseven Türkiye 10 88 0.3× 484 1.8× 118 0.6× 62 0.4× 74 0.6× 16 724

Countries citing papers authored by Eileen Holovac

Since Specialization
Citations

This map shows the geographic impact of Eileen Holovac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Holovac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Holovac more than expected).

Fields of papers citing papers by Eileen Holovac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen Holovac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Holovac. The network helps show where Eileen Holovac may publish in the future.

Co-authorship network of co-authors of Eileen Holovac

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen Holovac. A scholar is included among the top collaborators of Eileen Holovac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen Holovac. Eileen Holovac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Alsuhebany, Nada, et al.. (2023). Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehensive Review. PubMed. Volume 13. 67–76. 4 indexed citations
2.
Lee, Tiffany, et al.. (2021). A Stepwise Approach for Preventing Suicide by Lethal Poisoning.. Federal Practitioner. 38(Jan 2021 Vol. 38 No. 1). 62–67. 4 indexed citations
3.
Hao, Enkui, Partha Mukhopadhyay, Zongxian Cao, et al.. (2015). Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis. Molecular Medicine. 21(1). 38–45. 138 indexed citations
4.
Mukhopadhyay, Partha, Mohanraj Rajesh, Zongxian Cao, et al.. (2013). Poly (ADP-Ribose) Polymerase-1 Is a Key Mediator of Liver Inflammation and Fibrosis. Hepatology. 59(5). 1998–2009. 105 indexed citations
5.
Cao, Zongxian, Melinda M. Mulvihill, Partha Mukhopadhyay, et al.. (2013). Monoacylglycerol Lipase Controls Endocannabinoid and Eicosanoid Signaling and Hepatic Injury in Mice. Gastroenterology. 144(4). 808–817.e15. 107 indexed citations
7.
Mukhopadhyay, Partha, Enkui Hao, Zongxian Cao, et al.. (2013). Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, and Cell Death in Doxorubicin Induced Cardiomyopathy. Free Radical Biology and Medicine. 65. S79–S79. 1 indexed citations
8.
Rajesh, Mohanraj, Sándor Bátkai, Malek Kechrid, et al.. (2012). Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy. Diabetes. 61(3). 716–727. 217 indexed citations
9.
Mukhopadhyay, Partha, Béla Horváth, Zsuzsanna K. Zsengellér, et al.. (2012). Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia–reperfusion: Therapeutic potential of mitochondrially targeted antioxidants. Free Radical Biology and Medicine. 53(5). 1123–1138. 116 indexed citations
10.
Mukhopadhyay, Partha, Béla Horváth, Zsuzsanna K. Zsengellér, et al.. (2011). Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy. Free Radical Biology and Medicine. 52(2). 497–506. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026